Table 1

Patient characteristics

Characteristicn%
Total15
 Male1173
 Female427
Age (yr)
 Median59
 Range46–78
Performance status
 01386
 1214
Prior treatment
 IL-21173
 Chemotherapy320
 None320
Nephrectomy1387
Dominant sites of disease
 Lung (lung only)10 (5)66
 Liver533
 Bone213
 Primary213
 Adrenal17
Time from diagnosis of stage 4 to study entry (mo)
 Median21
 Range5–34